1. Fu, X., Guadagni, F., and Hoffman, R.M. A metastatic nude-mouse
model of human pancreatic cancer constructed orthotopically from
histologically intact patient specimens. Proc. Natl. Acad. Sci. USA 89,
5645-5649, 1992.
2. Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman,
R.M. A novel "patient-like" treatment model of human pancreatic cancer
constructed using orthotopic transplantation of histologically intact
human tumor tissue in nude mice. Cancer Res. 53, 3070-3072, 1993.
3. An, Z., Wang, X., Kubota, T., Moossa, A.R., Hoffman, R.M. A clinical
nude mouse metastatic model for highly malignant human pancreatic cancer.
Anticancer Res. 16, 627-632, 1996.
4. Tomikawa, M., Kubota, T., Matsuzaki, S.W., Takahasi, S., Kitajima,
M., Moossa, A.R., and Hoffman, R.M. Mitomycin C and cisplatin increase
survival in a human pancreatic cancer metastatic model. Anticancer Res.
17, 3623-3626, 1997.
5. Bouvet, M., Yang, M., Nardin, S., Wang, X., Jiang, P., Baranov, E.,
Moossa, A.R., Hoffman, R.M. Chronologically-specific metastatic
targeting of human pancreatic tumors in orthotopic models. Clinical &
Experimental Metastasis 18, 213-218, 2000.
6. Lee, N.C., Bouvet, M., Nardin, S., Jiang, P., Baranov, E., Rashidi,
B., Yang, M., Wang, X., Moossa, A.R., and Hoffman, R.M. Antimetastatic
efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model.
Clinical & Experimental Metastasis 18, 379-384, 2001.
7. Bouvet, M., Wang, J-W., Nardin, S.R., Nassirpour, R., Yang, M.,
Baranov, E., Jiang, P., Moossa, A.R., and Hoffman, R.M. Real-time
optical imaging of primary tumor growth and multiple metastatic events
in a pancreatic cancer orthotopic model. Cancer Research, in press.
8. Bouvet, M., Nardin, S.R., Burton, D.W., Lee, N.C., Yang M., Wang, X.,
Baranov, E., Behling, C., Moosa, A.R., Hoffman R.M., and Deftos L.J.
Parathyroid hormone-related protein as a novel tumor marker in
pancreatic adenocarcinoma. Pancreas 24, 284-290, 2002.
9. Sun, F-X., Tohgo, A.,
Bouvet, M., Yagi, S., Nassirpour, R., Moossa, A.R., and Hoffman, R.M.
Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on
human pancreatic cancer in an orthotopic metastatic model.
Cancer Research 63,
80-85, 2003.
10. Katz,
M., Takimoto, S., Spivac, D., Moossa, A.R., Hoffman, R.M., Bouvet, M. A
novel red fluorescent protein orthotopic pancreatic cancer model for the
preclinical evaluation of chemotherapeutics. J.Surg. Res. 113,
151-160, 2003.
11. Katz,
M.H., Bouvet, M., Takimoto, S., Spivac, D., Moossa, A.R., Hoffman, R.M.
Selective antimetastatic activity of cytosine analog CS-682 in a red
fluorescent protein orthotopic model of pancreatic cancer. Cancer Res. 63,
5521-5525, 2003.
12.
Tsuji, K., Yamauchi, K., Jiang, P., Yang, M., and Hoffman, R.M.
Common bile duct injection as a novel method for establishing
RFP-expressing human pancreatic cancer in nude mice. Journal of the
Pancreas 7, 193-199, 2006.
13. Katz, M., Spivac, D., Takimoto, S., Bouvet, M., Moosa, A.R., R.M.
Hoffman. An imageable highly metastatic orthotopic red fluorescent
protein model of pancreatic cancer. Clin. Exp. Metastasis 21, 7-12,
2004.
14. Katz, M.H., Bouvet, M., Takimoto, S., Spivack, D., Moosa, A.R.,
and Hoffman, R.M. Survival efficacy of adjuvant cytosine-analogue CS-682
in a fluorescent orthotopic model of human pancreatic cancer. Cancer
Research 64, 1828-1833, 2004.
15. Bouvet, M., Spernyak, J., Katz,
M.H., Mazurchuk, R.V., Takimoto, S., Bernacki, R., Rustum, Y.M., Moossa,
A.R., and Hoffman, R.M. High correlation of whole- body red fluorescent
protein imaging and magnetic resonance imaging on an orthotopic model of
pancreatic cancer. Cancer Research 65, 9829-9833, 2005.
16. Amoh, Y., Li, L., Tsuji, K., Moosa, A.R., Katsuoka, K., Hoffman,
R.M., Bouvet, M. Dual-color imaging of nascent blood vessels
vascularizing pancreatic cancer in an orthotopic model demonstrates
antioangiogenesis efficacy of gemcitabine. J. Surgical Research 132,
164-169, 2006.
